Axim Biotechnologies Inc (AXIM)

Currency in USD
0.01
0.00(0.00%)
Closed·
Advertisement
Trading near 52-week Low
AXIM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.010.01
52 wk Range
0.010.03
Key Statistics
Prev. Close
-
Open
0.01
Day's Range
0.01-0.01
52 wk Range
0.01-0.03
Volume
-
Average Volume (3m)
1.44M
1-Year Change
5.7082%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AXIM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a poor free cash flow yield

Axim Biotechnologies Inc News & Analysis

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Earnings

Latest Release
19/08/2024
EPS / Forecast
-0.01 / --
Revenue / Forecast
17.48K / --
EPS Revisions
Last 90 days

Axim (AXIM) Income Statement & Profits

Compare AXIM to Peers and Sector

Metrics to compare
AXIM
Peers
Sector
Relationship
P/E Ratio
0.0x−1.6x−0.2x
PEG Ratio
0.000.010.00
Price/Book
0.0x2.1x2.6x
Price / LTM Sales
0.0x5.4x2.8x
Upside (Analyst Target)
-129.1%60.9%
Fair Value Upside
Unlock15.3%9.5%Unlock

AXIM Biotechnologies, Inc. develops diagnostic healthcare solutions for ophthalmological conditions. It develops and commercializes two point-of-care diagnostic tests to assist eye-care physicians in detecting and quantifying biomarkers associated with aqueous deficient dry eye disease and non-specific allergic conjunctivitis, including ocular total immunoglobulin E allergy test and lactoferrin ADDE test. It also operates a full-service center for custom biomarker and biopharmaceutical research, custom assay development, clinical sample testing, and precision data delivery. In addition, the company develops a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring, as well as COVID-19 rapid diagnostic tools. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.

People Also Watch

0.068
ACB
0.00%
0.000100
EVIO
0.00%
0.000200
GBLX
0.00%
0.0001
PHOT
-50.00%
0.200
SMG_old
0.00%

FAQ

What Is the Axim (OTC Markets: AXIM) Share Price Today?

The Axim stock price today is 0.01 USD.

What Stock Exchange Does Axim (AXIM) Trade On?

Axim is listed and trades on the OTC Markets.

What Is the Ticker (Stock Symbol) for Axim?

The stock symbol (also called a 'ticker') for Axim is "AXIM."

What Is the Current Axim Market Capitalisation?

As of today, Axim (OTC Markets: AXIM) market cap is 1.17M USD.

Is AXIM a Buy or Sell From a Technical Analyst Perspective?

Based on today's Axim moving averages and other technical indicators, the daily buy/sell signal for AXIM stock is Strong Buy.

How Many Times Has Axim Stock Split?

Axim has split 0 times. (See the AXIM stock split history page for full effective split date and price information.)

How Many Employees Does Axim Have?

Axim has 7 employees, based on their latest Companies House report.

What is the current trading status of Axim (OTC Markets: AXIM)?

As of 11/11/2026, Axim (AXIM) is trading at a share price of 0.01 USD, with a previous close of 0.00 USD. The stock has fluctuated within a day range of 0.01 USD to 0.01 USD, while its 52-week range spans from 0.01 USD to 0.03 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.